University Hospital Basel Liechti Lab Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first.

Matthias liechtiMiri halperin wernliExchange commissionUniversity hospital basel liechti labUniversity hospital basel liechti lab phaseMedicine mindmed incNature scientific reportsMed executive presidentProfessor liechtiMind medicine mindmed incHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesமீறி ஹால்பெரின் வெற்ணிலிபரிமாற்றம் தரகுஇயற்கை அறிவியல் அறிக்கைகள்